Merit Medical Systems (NASDAQ:MMSI) Stock Rating Lowered by Wall Street Zen

Merit Medical Systems (NASDAQ:MMSI) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report issued on Sunday.

MMSI has been the topic of a number of other reports. Barrington Research boosted their price target on Merit Medical Systems from $106.00 to $109.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. Needham & Company LLC reaffirmed a “buy” rating and issued a $101.00 target price on shares of Merit Medical Systems in a report on Wednesday. Piper Sandler cut their price target on Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Merit Medical Systems in a research report on Friday, March 27th. Finally, Robert W. Baird set a $108.00 price objective on shares of Merit Medical Systems in a research note on Tuesday, December 16th. Seven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.25.

Merit Medical Systems Stock Performance

Merit Medical Systems stock opened at $67.70 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.95 and a current ratio of 4.34. The firm has a market capitalization of $4.04 billion, a PE ratio of 31.93, a PEG ratio of 1.95 and a beta of 0.64. Merit Medical Systems has a 52 week low of $66.34 and a 52 week high of $106.11. The business’s 50-day simple moving average is $75.42 and its 200-day simple moving average is $81.59.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.08. The company had revenue of $393.94 million during the quarter, compared to analyst estimates of $390.77 million. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The company’s revenue was up 10.9% on a year-over-year basis. During the same quarter last year, the business posted $0.93 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Equities research analysts forecast that Merit Medical Systems will post 3.37 earnings per share for the current year.

Institutional Investors Weigh In On Merit Medical Systems

Several institutional investors have recently bought and sold shares of MMSI. Norden Group LLC grew its stake in Merit Medical Systems by 5.7% in the 3rd quarter. Norden Group LLC now owns 2,536 shares of the medical instruments supplier’s stock valued at $211,000 after purchasing an additional 137 shares during the period. Lido Advisors LLC grew its stake in Merit Medical Systems by 3.8% in the 4th quarter. Lido Advisors LLC now owns 3,836 shares of the medical instruments supplier’s stock valued at $324,000 after buying an additional 140 shares in the last quarter. Hilltop National Bank lifted its holdings in Merit Medical Systems by 8.7% during the 3rd quarter. Hilltop National Bank now owns 2,119 shares of the medical instruments supplier’s stock worth $176,000 after purchasing an additional 169 shares in the last quarter. Sowell Financial Services LLC grew its stake in Merit Medical Systems by 4.2% during the third quarter. Sowell Financial Services LLC now owns 4,355 shares of the medical instruments supplier’s stock valued at $362,000 after acquiring an additional 174 shares in the last quarter. Finally, Maryland State Retirement & Pension System increased its holdings in shares of Merit Medical Systems by 2.1% in the fourth quarter. Maryland State Retirement & Pension System now owns 8,693 shares of the medical instruments supplier’s stock worth $766,000 after purchasing an additional 180 shares during the period. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.